Showing 561 - 580 results of 801 for search '"insulin resistance"', query time: 0.06s Refine Results
  1. 561

    Anthropometric Indicators to Determine the Obesity and its Relations with the Cardiometabolic Risk by Raúl Cedeño Morales, Maricel Castellanos González, Mikhail Benet Rodríguez, Luis Mass Sosa, Carlos Mora Hernández, Jorge Carlos Parada Arias

    Published 2015-02-01
    “…<strong>Background:</strong> it has become a controversy if obesity per se is an independent cardiometabolic risk factor it self or it influences like a contributing element of other factors, specially hypertension, insulin resistance and dislipidemias. <strong><br />Objective:</strong> determining which of the anthropometric parameters used to quantify obesity is more associated to the cardiometabolic risk factors. …”
    Get full text
    Article
  2. 562

    Evaluation of Antidiabetic Properties of the Leaves Extract of Ficus vallis-choudae Delile in a Model of Type 2 Diabetes Induced by High-Fat Diet and Streptozotocin by Kilenma Kolefer, David Miaffo, Roger Ponka

    Published 2021-01-01
    “…The AEFV also lowered blood glucose levels, insulinemia, homeostatic model assessment of insulin resistance (HOMA-IR) index, and total cholesterol (TC), triglycerides (TG), low-density lipoproteins cholesterol (LDL-c), and very-low-density lipoproteins cholesterol (VLDL-c) levels. …”
    Get full text
    Article
  3. 563

    Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats by Sayin Fatma Kubra, Buyukbas Sadik, Basarali M. Kemal, Alp Harun, Toy Hatice, Ugurcu Veli

    Published 2016-03-01
    “…SME supplementation for different durations raised improvement in the HFD-induced metabolic disorders such as insulin resistance, hyperlipidemia and hepatopathy at different degrees. …”
    Get full text
    Article
  4. 564

    Metabolic Syndrome, Obesity, and Gastrointestinal Cancer by Shintaro Fujihara, Hirohito Mori, Hideki Kobara, Noriko Nishiyama, Mitsuyoshi Kobayashi, Makoto Oryu, Tsutomu Masaki

    Published 2012-01-01
    “…Adipose tissue, particularly visceral fat, is an important metabolic tissue as it secretes systemic factors that alter the immunologic, metabolic, and endocrine milieu and also promotes insulin resistance. Within the growth-promoting, proinflammatory environment of the obese state, cross-talk between macrophages, adipocytes, and epithelial cells occurs via obesity-associated hormones, adipocytokines, and other mediators that may enhance cancer risk and progression. …”
    Get full text
    Article
  5. 565

    Specific Metabolic Fingerprint of a Dietary Exposure to a Very Low Dose of Endosulfan by Cécile Canlet, Marie Tremblay-Franco, Roselyne Gautier, Jérôme Molina, Benjamin Métais, Florence Blas-Y Estrada, Laurence Gamet-Payrastre

    Published 2013-01-01
    “…In conclusion, our results show that metabolic changes in liver could be linked to the onset of pathologies like diabetes and insulin resistance. Moreover from our results it appears that the NMR-based metabonomic approach could be useful for the characterization in plasma of a dietary exposure to low dose of pesticide in human.…”
    Get full text
    Article
  6. 566
  7. 567

    Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1 by XingChun Wang, Huan Liu, Jiaqi Chen, Yan Li, Shen Qu

    Published 2015-01-01
    “…The impaired secretion of glucagon-like peptide-1 has negative influence on diabetes, hyperlipidemia, and insulin resistance related diseases. Thus, glucagon-like peptide-1-based therapies (glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors) are now well accepted in the management of type 2 diabetes. …”
    Get full text
    Article
  8. 568

    Interleukin-4 Promotes Myogenesis and Boosts Myocyte Insulin Efficacy by Yih-Hsin Chang, Jen-Ning Tsai, Tzu-Lin Chen, Kuo-Ting Ho, Hsin-Yi Cheng, Chiao-Wan Hsiao, Ming-Yuh Shiau

    Published 2019-01-01
    “…IL-4 has dual potential to act as an adjuvant therapeutic target for sarcopenia to preserve muscle mass and insulin resistance to improve insulin sensitivity, which implicates the regulation of immune system to the muscle differentiation and exercise performance.…”
    Get full text
    Article
  9. 569

    Early Postoperative Outcomes and Medication Cost Savings after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients with Type 2 Diabetes by Bethany J. Slater, Nina Bellatorre, Dan Eisenberg

    Published 2011-01-01
    “…Age, gender, body mass index (BMI), diabetic medication use, glucose, insulin, and HbA1c levels were documented preoperatively, and at 2 weeks, 2 months, 6 months, and 12 months postoperatively. Insulin resistance was estimated using the homeostatic model assessment (HOMA). …”
    Get full text
    Article
  10. 570

    Association of age at menopause with type 2 diabetes mellitus in postmenopausal women: a systematic review and meta-analysis by Faezeh Zakerinasab, Taif Haiham Al Saraireh, Amirhesam Amirbeik, Rasoul Hossein Zadeh, Fariba Arbab Mojeni, Qumars Behfar

    Published 2024-12-01
    “…Visceral obesity and diminished estrogen level during the menopausal phase are associated with unfavorable metabolic changes, resulting in insulin resistance and increased risk of type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  11. 571

    Free Triiodothyronine and Cholesterol Levels in Euthyroid Elderly T2DM Patients by F. Strollo, I. Carucci, M. Morè, G. Marico, G. Strollo, M. A. Masini, S. Gentile

    Published 2012-01-01
    “…Recent literature reports upon complex hypothalamic and peripheral interactions between T2DM and thyroid, and suggests T3 to enhance cholesterol synthesis and to have a role in insulin resistance states. Further investigations are needed to understand the intimate mechanisms of lipid metabolism in T2DM with respect to thyroid function.…”
    Get full text
    Article
  12. 572

    OSAS-Related Inflammatory Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease by Elena Paschetta, Paola Belci, Anna Alisi, Daniela Liccardo, Renato Cutrera, Giovanni Musso, Valerio Nobili

    Published 2015-01-01
    “…In NAFLD patients, liver disease may be caused by hypoxia both indirectly by promoting inflammation and insulin resistance and directly by enhancing proinflammatory cytokine production and metabolic dysregulation in liver cells. …”
    Get full text
    Article
  13. 573

    Garlic and Onion Attenuates Vascular Inflammation and Oxidative Stress in Fructose-Fed Rats by Marcela Alejandra Vazquez-Prieto, Cecilia Rodriguez Lanzi, Carina Lembo, Claudio Rómulo Galmarini, Roberto Miguel Miatello

    Published 2011-01-01
    “…At the end of the study, FFR had developed insulin resistance, aortic NADPH oxidase activity, increased SBP, plasma TBARS and vascular cell adhesion molecule-1 (VCAM-1) expression in mesenteric arteries, and a decrease in heart endothelial nitric oxide synthase (eNOS). …”
    Get full text
    Article
  14. 574

    Toll-Like Receptor-4 Mediated Inflammation Is Involved in the Cardiometabolic Alterations Induced by Intermittent Hypoxia by Laureline Poulain, Vincent Richard, Patrick Lévy, Maurice Dematteis, Claire Arnaud

    Published 2015-01-01
    “…Results. IH induced insulin resistance, morphological and inflammatory changes of the epididymal fat (smaller pads and adipocytes, higher release of TNF-α and IL-6) and aorta (larger intima-media thickness and higher NFκB-p50 activity). …”
    Get full text
    Article
  15. 575

    Association of Serum Gamma-Glutamyl Transferase and Ferritin with the Metabolic Syndrome by Dong Wei, Tao Chen, Jie Li, Yun Gao, Yan Ren, Xiangxun Zhang, Hongling Yu, Haoming Tian

    Published 2015-01-01
    “…Furthermore, the increased risk of having each of the metabolic syndrome components (overweight or obesity, hypertriglyceridemia, hypertension, hyperglycemia, and insulin resistance) was also observed in those subjects after adjustment for possible confounders (p < 0.05). …”
    Get full text
    Article
  16. 576

    A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women by Elena Passeri, Stefano Benedini, Elena Costa, Sabrina Corbetta

    Published 2015-01-01
    “…Nonetheless, 60 mg denosumab induced a significant reduction in the hepatic insulin resistance index at 4 weeks and in HbA1c levels at 12 weeks. …”
    Get full text
    Article
  17. 577

    Antimutagenic Effect of Hibiscus sabdariffa L. Aqueous Extract on Rats Treated with Monosodium Glutamate by Ana Carla Guidini Valentini Gheller, Jacqueline Kerkhoff, Gerardo Magela Vieira Júnior, Kleber Eduardo de Campos, Marina Mariko Sugui

    Published 2017-01-01
    “…H. sabdariffa is known to contain antioxidant, cholesterol-lowering, antiobesity, insulin resistance reduction, antihypertensive, and skin cancer chemopreventive properties. …”
    Get full text
    Article
  18. 578

    Oral Administration of the Endocannabinoid Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and Food Intake in Adult Mice by Carolina Aguirre, Valeska Castillo, Miguel Llanos

    Published 2017-01-01
    “…We have previously shown that administration of the endocannabinoid anandamide (AEA) during lactation leads to overweight, increased body fat accumulation, and insulin resistance in adult mice. This study was designed to elucidate if these effects are due to increased food intake, stimulated by an augmented abundance and binding ability of the hypothalamic cannabinoid type 1 receptor (CB1R). …”
    Get full text
    Article
  19. 579

    Concentrations of Selected Adipokines, Interleukin-6, and Vitamin D in Patients with Papillary Thyroid Carcinoma in Respect to Thyroid Cancer Stages by Jakub Warakomski, Ewa Romuk, Barbara Jarząb, Jolanta Krajewska, Lucyna Siemińska

    Published 2018-01-01
    “…No significant relationships between serum concentrations of leptin, adiponectin, chemerin, IL-6, vitamin D, and tumor size in PTC were found. Although insulin resistance represented by the HOMA index was associated with anthropometric variables and with serum leptin, adiponectin, chemerin, and IL-6 concentrations, in our study, no statistically significant relations with PTC staging were identified.…”
    Get full text
    Article
  20. 580

    All-Cause Mortality Risk of Metabolically Healthy Obese Individuals in NHANES III by C. M. Durward, T. J. Hartman, S. M. Nickols-Richardson

    Published 2012-01-01
    “…Metabolic health was defined as: (1) homeostasis model assessment-insulin resistance (HOMA-IR) <2.5; (2) ≤2 Adult Treatment Panel (ATP) III metabolic syndrome criteria; (3) combined definition using ≤1 of the following: HOMA-IR ≥1.95 (or diabetes medications), triglycerides ≥1.7 mmol/L, HDL-C <1.04 mmol/L (males) or <1.30 mmol/L (females), LDL-C ≥2.6 mmol/L, and total cholesterol ≥5.2 mmol/L (or cholesterol-lowering medications). …”
    Get full text
    Article